BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis
NASDAQ:BTSG - Nasdaq - US10950A1060 - Common Stock - Currency: USD
BTSG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. While BTSG is still in line with the averages on profitability rating, there are concerns on its financial health. BTSG has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
BTSG had positive earnings in the past year.
BTSG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BTSG reported negative net income in multiple years.
BTSG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.98%, BTSG is in line with its industry, outperforming 51.46% of the companies in the same industry.
BTSG has a Return On Equity of 3.39%. This is comparable to the rest of the industry: BTSG outperforms 57.28% of its industry peers.
BTSG has a Return On Invested Capital (4.48%) which is in line with its industry peers.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.70%.
The last Return On Invested Capital (4.48%) for BTSG is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 3.39% | ||
| ROIC | 4.48% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
1.3 Margins
BTSG has a Profit Margin (0.49%) which is in line with its industry peers.
BTSG has a Operating Margin (2.15%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BTSG has grown nicely.
BTSG has a worse Gross Margin (13.46%) than 69.90% of its industry peers.
BTSG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.15% | ||
| PM (TTM) | 0.49% | ||
| GM | 13.46% |
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BTSG is destroying value.
The number of shares outstanding for BTSG has been increased compared to 1 year ago.
BTSG has more shares outstanding than it did 5 years ago.
BTSG has a better debt/assets ratio than last year.
2.2 Solvency
BTSG has an Altman-Z score of 2.82. This is not the best score and indicates that BTSG is in the grey zone with still only limited risk for bankruptcy at the moment.
BTSG has a Altman-Z score of 2.82. This is in the better half of the industry: BTSG outperforms 60.19% of its industry peers.
BTSG has a debt to FCF ratio of 19.98. This is a negative value and a sign of low solvency as BTSG would need 19.98 years to pay back of all of its debts.
The Debt to FCF ratio of BTSG (19.98) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.48 is on the high side and indicates that BTSG has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.48, BTSG is doing worse than 70.87% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.48 | ||
| Debt/FCF | 19.98 | ||
| Altman-Z | 2.82 |
ROIC/WACC0.53
WACC8.45%
2.3 Liquidity
BTSG has a Current Ratio of 1.73. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BTSG (1.73) is better than 62.14% of its industry peers.
A Quick Ratio of 1.37 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG's Quick ratio of 1.37 is in line compared to the rest of the industry. BTSG outperforms 51.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
BTSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 122.31%, which is quite impressive.
BTSG shows a small growth in Revenue. In the last year, the Revenue has grown by 1.45%.
The Revenue has been growing by 20.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%
3.2 Future
BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.97% yearly.
The Revenue is expected to grow by 7.63% on average over the next years.
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue Next Year9.95%
Revenue Next 2Y11.22%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 33.45 indicates a quite expensive valuation of BTSG.
BTSG's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.35, BTSG is valued a bit more expensive.
With a Price/Forward Earnings ratio of 19.42, BTSG is valued on the expensive side.
BTSG's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 37.54. BTSG is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.45 | ||
| Fwd PE | 19.42 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as BTSG.
BTSG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.69 | ||
| EV/EBITDA | 13.74 |
4.3 Compensation for Growth
BTSG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTSG's earnings are expected to grow with 31.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y39.35%
EPS Next 3Y31.48%
5. Dividend
5.1 Amount
BTSG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:BTSG (7/25/2025, 9:57:04 AM)
20.74
+0.08 (+0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.2%
Inst Owner Change-0.03%
Ins Owners2.93%
Ins Owner Change11.51%
Market Cap3.66B
Analysts84.21
Price Target28.67 (38.24%)
Short Float %17.58%
Short Ratio5.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.71%
PT rev (3m)13.87%
EPS NQ rev (1m)7.14%
EPS NQ rev (3m)39.29%
EPS NY rev (1m)1.38%
EPS NY rev (3m)47.27%
Revenue NQ rev (1m)0.49%
Revenue NQ rev (3m)3.17%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)3.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.45 | ||
| Fwd PE | 19.42 | ||
| P/S | 0.32 | ||
| P/FCF | 28.69 | ||
| P/OCF | 17.91 | ||
| P/B | 2.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.74 |
EPS(TTM)0.62
EY2.99%
EPS(NY)1.07
Fwd EY5.15%
FCF(TTM)0.72
FCFY3.49%
OCF(TTM)1.16
OCFY5.58%
SpS65.58
BVpS9.57
TBVpS-7.09
PEG (NY)0.59
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.98% | ||
| ROE | 3.39% | ||
| ROCE | 5.67% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.54% | ||
| ROICexgc | 14.07% | ||
| OM | 2.15% | ||
| PM (TTM) | 0.49% | ||
| GM | 13.46% | ||
| FCFM | 1.1% |
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.48 | ||
| Debt/FCF | 19.98 | ||
| Debt/EBITDA | 5.59 | ||
| Cap/Depr | 38.81% | ||
| Cap/Sales | 0.66% | ||
| Interest Coverage | 1.22 | ||
| Cash Conversion | 45.71% | ||
| Profit Quality | 222.79% | ||
| Current Ratio | 1.73 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 2.82 |
F-Score6
WACC8.45%
ROIC/WACC0.53
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%
Revenue Next Year9.95%
Revenue Next 2Y11.22%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year54.27%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%